Abstract:As one of the most frequent autoimmune diseases, Sjogren's syndrome (SS) is characterized by overactive lymphocytic infiltration in the exocrine glands, with ensuing dry mouth and dry eyes. Unfortunately, so far, there are no appropriate therapies without causing overall immunosuppression. Tetrahedral framework nucleic acids (tFNAs) were regarded as promising nanoscale materials whose immunomodulatory capabilities have already been verified. Herein, we reveal, for the first time, that tFNAs were utilized to treat SS in female nonobese diabetic (NOD) mice, the animal model used for SS. We proved a 250 nM tFNA treatment was successful in suppressing inflammation and stimulating saliva secretion in NOD mice. Specialised proteins for the secretory function and structure of acinar cells in submandibular glands (SMGs) were restored. It has been the permanent goal for SS treatment to establish immune tolerance and stop disease development. Surprisingly, tFNA treatment guided T cells toward regulatory T cells (Tregs), while suppressing T helper (Th) cell responses. Th cells include Th1, Th17, and follicular helper T (Tfh) cells. Tregs are highly significant in immune tolerance. Inducing Tregs is a promising approach to reestablish immune tolerance. Comparable results were also observed in B cell responses. Reductions in the percentage of germinal center (GC) B cells and plasma cells were detected, and a marked increase in the percentage of regulatory B cells (Bregs) was also noticed. The mechanisms of inducing Tregs may associated with cytokine changes. Changes of T cell subsets, especially changes of Tfh, may influence the differentiation of B cells accordingly. Collectively, our results demonstrated the immunomodulatory capacities of tFNAs once again, which may provide a novel, safe, and effective option for the treatment of SS and other autoimmune diseases.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c14861.Figure S1, AFM image of tFNAs; Figure S2, blood cytokine concentration at the end point of the experiment; Figure S3–S5, representative immunofluorescence images of SMGs; Figure S6–S7, representative flow cytometry pattern and quantitative analyses of CD4+ T cell subsets; Figure S8, quantitative analysis of Th2 in SMGs; Figures S9 and S10, representative flow cytometry pattern and quantitative analyses of B cell subsets; Figure S11, representative histological images of heart, liver, lung, and kidney (PDF)This article has not yet been cited by other publications.

Detection of T Follicular Helper Cells and T Follicular Regulatory Cells in Experimental Sjögren's Syndrome.

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjogren's syndrome

Tph Cells Expanded in Primary Sjögren’s Syndrome

Immune skew of follicular helper T cells and effector T cells in patients with Sjögren's syndrome

Unraveling the transcriptome-based network of tfh cells in primary sjogren syndrome: insights from a systems biology approach

Regulatory T cells and IFN-γ-producing Th1 cells play a critical role in the pathogenesis of Sjögren's Syndrome

[Research Updates: the Role of T Follicular Helper Cells in Sjogren's Syndrome].

Subpopulation dynamics of T and B lymphocytes in Sjögren's syndrome: implications for disease activity and treatment

Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models

Identification and Verification of Inflammatory Biomarkers for Primary Sjögren’s Syndrome

The Immune Factors Involved in the Pathogenesis, Diagnosis, and Treatment of Sjogren's Syndrome

Tetrahedral Framework Nucleic Acids Reestablish Immune Tolerance and Restore Saliva Secretion in a Sjögren’s Syndrome Mouse Model

Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma

Exploiting the role of T cells in the pathogenesis of Sjögren's syndrome for therapeutic treatment

Immunobiology of T Cells in Sjögren’s Syndrome

Interaction of Human Salivary Gland Epithelial Cells with B Lymphocytes: Implications in the Pathogenesis of Sjögren’s Syndrome

Tissue resident memory CD8 T cells mediate salivary gland damage in a murine model of Sjögren's syndrome.

Analysis of Gene Expression and TCR/B Cell Receptor Profiling of Immune Cells in Primary Sjögren's Syndrome by Single-Cell Sequencing.

Analysis of Gene Expression and TCR/B Cell Receptor Profiling of Immune Cells in Primary Sjogren?s Syndrome by Single-Cell Sequencing

IL-10-producing Regulatory B Cells Restrain the T Follicular Helper Cell Response in Primary Sjögren's Syndrome.